Abnormal Biliary Lipid Composition in Cystic Fibrosis: Effect of Pancreatic Enzymes

New England Journal of Medicine

Volumn 297, Issue 24, 1977, Pages 1301-1305

  Roy, Claude C ^a   Weber, Andrée M ^a   Morin, Claude L ^a   Combes, Jean Claude ^a   Nusslé, Daniel ^a   Mégevand, Albert ^a   Lasalle, Roger ^a   Chartrand, Liette ^a   Lepage, Guy ^a   Fontaine, André ^a  

^a Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; NORDEOXYCHOLIC ACID; PANCREAS ENZYME; PANCREATIN; PANCRELIPASE; PANKROTANON; UNCLASSIFIED DRUG;

ARTICLE; BILE; CHILD; CHOLELITHIASIS; CYSTIC FIBROSIS; GALLSTONE; LIPID BILE LEVEL; MAJOR CLINICAL STUDY;

EID: 0017665648     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197712152972401     Document Type: Article

References (38)

1. Calabrese C, Pearlman DM: Gallbladder disease below the age of 21 years. Surgery 70: 413–415, 1971
2. Von Bergmann J, Von Bergmann K, Hadorn B, et al: Biliary lipid composition in early childhood. Clin Chim Acta 64: 241–246, 1975
3. Andrassy RJ, Treadwell TA, Ratner IA, et al: Gallbladder disease in children and adolescents. Am J Surg 132: 19–21, 1976
4. Weber AM, Roy CC, Morin CL, et al: Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 289: 1001–1005, 1973
5. Goodchild MC, Murphy GM, Howell AM, et al: Aspects of bile acid metabolism in cystic fibrosis. Arch Dis Child 50: 769–779, 1975
6. Watkins JB, Tercyak AM, Szczepanik P, et al: Bile salt kinetics in cystic fibrosis. Gastroenterology 67: 835, 1974
7. Rovsing H, Sloth K: Micro-gallbladder and biliary calculi in mucoviscidosis. Acta Radiol 14: 588–592, 1973
8. Fiegelson J, Pecau Y, Sauvegrain J: Liver function studies and biliary tract investigations in mucoviscidosis. Acta Paediatr Scand 59: 539–544, 1970
9. Courchaine AJ, Miller WH, Stein DB Jr: Rapid semimicro procedure for estimating free and total cholesterol. Clin Chem 5: 609–614, 1959
10. Bartlett GR: Phosphorous assay in column chromatography. J Biol Chem 234: 466–468, 1959
11. Weber AM, Chartrand L, Doyon G, et al: The quantitative determination of fecal bile acids in children by the enzymatic method. Clin Chim Acta 39: 524–531, 1972
12. Hofmann AF: Thin-layer adsorption chromatography of free and conjugated bile acids on silicic acid. J Lipid Res 3: 127–128, 1962
13. Rudman D, Kendall FE: Bile acid content of human serum. I. Serum bile acids in patients with hepatic disease. J Clin Invest 36: 530–537, 1957
14. Eneroth P, Sjovall J: Extraction, purification and Chromatographic analysis of bile acids in biological materials, The Bile Acids. Vol 1. Edited by PP Nair, D Kritchevsky. New York, Plenum Press, 1971, pp 121–171
15. Evrard E, Janssen G: Gas-liquid chromatography determination of human fecal bile acids. J Lipid Res 9: 226–237, 1968
16. Roovers J, Evrard E, Vanderhaeghe H: An improved method for measuring human blood bile acids. Clin Chim Acta 19: 449–457, 1968
17. Admirand WH, Small DM: The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 47: 1043–1052, 1968
18. Thomas PJ, Hofmann AF: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates. Gastroenterology 65: 698–700, 1973
19. Scheffé H: A method for judging all contrasts in the analysis of variance. Biometrika 40: 87–104, 1953
20. Weber AM, Roy CC, Chartrand L, et al: Relationship between bile acid malabsorption and pancreatic insufficiency in cystic fibrosis. Gut 17: 295–299, 1976
21. Harries JT, Muller DPR, Mathias P, et al: Factors influencing serum concentrations of vitamin E and fatty acids in cystic fibrosis. Presented at the seventh International Cystic Fibrosis Congress, Paris, May 31–June 3, 1976
22. Palmer RH: The gallbladder and bile composition. Am J Dig Dis 21: 795–796, 1976
23. Dowling RH, Bell GD, White J: Lithogenic bile in patients with ileal dysfunction. Gut 13: 415–420, 1972
24. Heaton KW, Read AE: Gall stones in patients with disorders of the terminal ileum and disturbed bile salt metabolism. Br Med J 3: 494–496, 1969
25. Garbutt JT, Heaton KW, Lack L, et al: Increased ratio of glycine- to taurine-conjugated bile salts in patients with ileal disorders. Gastroenterology 56: 711–720, 1969
26. Grundy SM, Metzger AL: A physiological method for estimation of hepatic secreion of biliary lipids in man. Gastroenterology 62: 1200–1217, 1972
27. Shaffer EA, Braasch JW, Small DM: Bile composition at and after surgery in normal persons and patients with gallstones: influence of cholecystectomy. N Engl J Med 287: 1317–1322, 1972
28. Shaffer EA, Small DM: Biliary lipid secretion in cholesterol gallstone disease: the effect of cholecystectomy and obesity. J Clin Invest 49: 828–840, 1977
29. Redinger RN: The effect of loss of gallbladder function on biliary lipid composition in subjects with cholesterol gallstones. Gastroenterology 71: 470–474, 1976
30. Hepner GW, Hofmann AF, Malagelada JR, et al: Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology 66: 556–564, 1974
31. Isenberg JN, L'Heureux P, Warwick WJ, et al: Detection of cirrhosis in cystic fibrosis: lack of correlation with gamma glutamyl transpeptidase and biliary tract roentgenograms. Gastroenterology 66: 887, 1974
32. Danzinger RG, Hofmann AF, Schoenfield LJ, et al: Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med 286: 1–8, 1972
33. Alder RD, Bennion LJ, Duane WC, et al: Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism. Gastroenterology 68: 326–334, 1975
34. Coyne MJ, Bonorris GG, Goldstein LI, et al: Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of the hepatic cholesterol and bile acid synthesis in patients with gallstones. J Lab Clin Med 87: 281–291, 1976
35. Thistle JL, Hofmann AF: Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. N Engl J Med 289: 655–659, 1973
36. Oppenheimer EH, Esterly JR: Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis. J Pediatr 86: 683–689, 1975
37. Stern RC, Stevens DP, Boat TF, et al: Symptomatic hepatic disease in cystic fibrosis: incidence, course, and outcome of portal systemic shunting. Gastroenterology 70: 645–649, 1976
38. Schwachman H: Gastrointestinal manifestations of cystic fibrosis. Pediatr Clin North Am 22: 787–805, 1975